RepliCel Life Sciences (TSE:RP) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
RepliCel Life Sciences is urging shareholders to access its management information circular online due to possible postal delays caused by a Canada Post labor disruption. The company is preparing for a critical shareholders meeting to discuss the sale and licensing of its assets and potential delisting.
For further insights into TSE:RP stock, check out TipRanks’ Stock Analysis page.